About Arvee Laboratories (India) Limited
Data last updated:
Arvee Laboratories (India) Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 27 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24231GJ2012PLC068778. Its GSTIN is 24AAKCA2207N1ZQ (Gujarat). Its shares are listed on NSE: ARVEE.
The company has an authorised share capital of ₹11.25 Cr and a paid-up capital of ₹11.02 Cr. It was formerly known as Arvee Laboratories (India) Private Limited. It is led by directors including Shalin Sudhakarbhai Patel and Neetu Jalan.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 403 Entice Nr. Jayantilal Park Brts Iscon Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹31.51 Cr, a decline of 18.1% compared to the previous year. For the same year it recorded a net profit of ₹2.39 Cr (net margin 7.6%) and EBITDA of ₹3.2 Cr (EBITDA margin 10.2%). The net worth stands at ₹33.79 Cr (up 8.1% YoY). Total assets are valued at ₹35.39 Cr (up 8% YoY).
The company has about 66 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Arvee Laboratories. As per MCA filings, the company has open charges of ₹20.5 Cr and satisfied charges of ₹15 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it. The company has 1 deal on record (1 ipo); the latest was in February 2018. Its 10 peer companies in the Chemicals industry (Specialty Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Vimson Coatings Private Limited with revenue of ₹39.93 Cr. The company has 3 MSME Form 1 returns on record for the period ending Mar 2023, listing 83 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arveelabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address403 Entice Nr. Jayantilal Park Brts Iscon Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058
- IndustryChemicals and Materials, Specialty Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arvee Laboratories (India) Limited
The main business activity of Arvee Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arvee Laboratories (India) Limited FY 2025-26 filings available
Arvee Laboratories (India) Limited reported revenue of ₹31.51 Cr (down 18.1% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 31.51 | 38.49 | 30.35 | 61.35 | 40.33 | 47.38 | 45.42 |
| Revenue growth | -18.1% | +26.8% | -50.5% | +52.1% | -14.9% | +4.3% | - |
| EBITDA | 3.20 | 3.62 | 2.94 | 7.28 | 5.68 | 6.04 | 6.02 |
| EBITDA margin | +10.2% | +9.4% | +9.7% | +11.9% | +14.1% | +12.8% | +13.3% |
| Profit before tax | 2.45 | 2.88 | 1.83 | 6.16 | 3.45 | 3.63 | 3.09 |
| Net profit | 2.39 | 1.99 | 1.01 | 4.10 | 2.48 | 2.48 | 2.15 |
| Net profit margin | +7.6% | +5.2% | +3.3% | +6.7% | +6.2% | +5.2% | +4.7% |
| EPS (₹) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | 4.17 |
| Balance sheet | |||||||
| Total assets | 35.39 | 32.77 | 30.59 | 29.35 | 27.07 | 30.32 | 22.63 |
| Net worth | 33.79 | 31.26 | 29.11 | 28.06 | 23.94 | 21.44 | 18.76 |
| Total debt | 1.11 | 1.03 | 1.00 | 1.00 | 3.13 | 8.88 | 3.87 |
| Cash & bank | 1.57 | 4.91 | 1.87 | 0.89 | 4.63 | 6.61 | 0.98 |
| Net working capital | 16.10 | 15.84 | 9.86 | 12.73 | 12.29 | 13.11 | 4.18 |
| Cash flow | |||||||
| Cash from operations | (0.12) | (0.21) | 3.66 | 2.93 | 0.68 | 1.71 | 10.31 |
| Cash from investing | 0.50 | (1.32) | (2.16) | (1.26) | 0.06 | (0.60) | (3.08) |
| Cash from financing | (0.16) | (0.12) | (0.19) | (2.42) | (6.06) | 4.52 | (9.90) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.23 | 10.80 | 9.78 | 3.45 | 7.48 | 6.45 | 8.91 | 12.53 |
| Revenue growth (YoY) | +130.4% | +67.4% | +9.8% | -72.5% | -29.4% | - | - | - |
| Other income | 0.18 | 0.15 | 0.14 | 0.23 | 0.17 | 0.21 | 0.19 | 0.16 |
| Total expenses | 14.73 | 9.70 | 8.16 | 3.32 | 7.14 | 6.23 | 8.56 | 11.02 |
| EBITDA | 2.50 | 1.10 | 1.62 | 0.13 | 0.34 | 0.22 | 0.35 | 1.51 |
| EBITDA margin | +14.5% | +10.2% | +16.6% | +3.8% | +4.5% | +3.4% | +3.9% | +12.1% |
| Depreciation | 0.32 | 0.31 | 0.30 | 0.30 | 0.29 | 0.27 | 0.28 | 0.30 |
| Interest | 0.06 | 0.08 | 0.07 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 |
| Profit before tax | 2.30 | 0.86 | 1.39 | 0.02 | 0.18 | 0.09 | 0.21 | 1.32 |
| Tax | 0.60 | 0.33 | (0.43) | 0.00 | 0.01 | 0.02 | 0.05 | 0.33 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.23 | 10.80 | 9.78 | 3.45 | 7.48 | 6.45 | 8.91 | 12.53 |
| Revenue growth (YoY) | +130.4% | +67.4% | +9.8% | -72.5% | -29.4% | - | - | - |
| Other income | 0.18 | 0.15 | 0.14 | 0.23 | 0.17 | 0.21 | 0.19 | 0.16 |
| Total expenses | 14.73 | 9.70 | 8.16 | 3.32 | 7.14 | 6.23 | 8.56 | 11.02 |
| EBITDA | 2.50 | 1.10 | 1.62 | 0.13 | 0.34 | 0.22 | 0.35 | 1.51 |
| EBITDA margin | +14.5% | +10.2% | +16.6% | +3.8% | +4.5% | +3.4% | +3.9% | +12.1% |
| Depreciation | 0.32 | 0.31 | 0.30 | 0.30 | 0.29 | 0.27 | 0.28 | 0.30 |
| Interest | 0.06 | 0.08 | 0.07 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 |
| Profit before tax | 2.30 | 0.86 | 1.39 | 0.02 | 0.18 | 0.09 | 0.21 | 1.32 |
| Tax | 0.60 | 0.33 | (0.43) | 0.00 | 0.01 | 0.02 | 0.05 | 0.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 31.51 | 38.49 | 30.35 | 61.35 | 40.33 | 47.38 | 45.42 |
| Revenue growth | -18.1% | +26.8% | -50.5% | +52.1% | -14.9% | +4.3% | - |
| Other income | 0.69 | 0.66 | 0.64 | 1.35 | 0.46 | 0.58 | 0.35 |
| Total expenses | 28.31 | 34.87 | 27.41 | 54.07 | 34.65 | 41.34 | 39.40 |
| Employee cost | 6.03 | 6.25 | 5.93 | 6.14 | 5.69 | 5.54 | 2.79 |
| EBITDA | 3.20 | 3.62 | 2.94 | 7.28 | 5.68 | 6.04 | 6.02 |
| EBITDA margin | +10.2% | +9.4% | +9.7% | +11.9% | +14.1% | +12.8% | +13.3% |
| Depreciation | 1.21 | 1.15 | 1.50 | 2.08 | 2.32 | 2.41 | 2.29 |
| Interest | 0.23 | 0.25 | 0.25 | 0.39 | 0.37 | 0.58 | 0.99 |
| Profit before tax | 2.45 | 2.88 | 1.83 | 6.16 | 3.45 | 3.63 | 3.09 |
| Tax | (0.09) | 0.72 | 0.78 | 2.05 | 0.88 | 0.96 | 0.80 |
| Net profit | 2.39 | 1.99 | 1.01 | 4.10 | 2.48 | 2.48 | 2.15 |
| Net profit margin | +7.6% | +5.2% | +3.3% | +6.7% | +6.2% | +5.2% | +4.7% |
| EPS (₹) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | 4.17 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.02 | 11.02 | 11.02 | 11.02 | 11.02 | 11.02 | 5.51 |
| Reserves & surplus | 22.77 | 20.24 | 18.09 | 17.04 | 12.92 | 10.42 | 13.25 |
| Shareholders' funds (net worth) | 33.79 | 31.26 | 29.11 | 28.06 | 23.94 | 21.44 | 18.76 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 2.13 | 8.88 | 4.70 |
| Unsecured loans | 1.11 | 1.03 | 1.00 | 1.00 | 1.00 | 0.00 | (0.83) |
| Total debt | 1.11 | 1.03 | 1.00 | 1.00 | 3.13 | 8.88 | 3.87 |
| Total liabilities | 35.39 | 32.77 | 30.59 | 29.35 | 27.07 | 30.32 | 22.63 |
| Assets | |||||||
| Gross block | 38.58 | 35.92 | 32.18 | 30.69 | 27.44 | 27.44 | 24.46 |
| Net block | 16.71 | 15.27 | 12.67 | 12.68 | 13.84 | 13.81 | 13.18 |
| Capital work in progress | 0.90 | 0.73 | 2.62 | 1.53 | 0.98 | 0.97 | 1.78 |
| Investments | 1.70 | 0.00 | 0.00 | 0.00 | 0.00 | 2.03 | 3.09 |
| Inventories | 9.19 | 4.55 | 6.40 | 4.57 | 5.73 | 7.43 | 6.47 |
| Sundry debtors | 10.45 | 8.40 | 6.11 | 12.26 | 12.13 | 7.88 | 6.52 |
| Cash & bank balances | 1.57 | 4.91 | 1.87 | 0.89 | 4.63 | 6.61 | 0.98 |
| Loans & advances | 1.88 | 1.81 | 2.61 | 3.85 | 1.21 | 1.60 | 0.79 |
| Total current assets | 23.09 | 19.67 | 16.99 | 21.57 | 23.70 | 23.52 | 14.76 |
| Total current liabilities | 6.99 | 3.83 | 7.13 | 8.84 | 11.41 | 10.41 | 10.58 |
| Net working capital | 16.10 | 15.84 | 9.86 | 12.73 | 12.29 | 13.11 | 4.18 |
| Total assets | 35.39 | 32.77 | 30.59 | 29.35 | 27.07 | 30.32 | 22.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.21 | 1.85 | 0.54 | 1.28 | 6.61 | 0.98 | 3.65 |
| Net cash from operating activities | (0.12) | (0.21) | 3.66 | 2.93 | 0.68 | 1.71 | 10.31 |
| Net cash from investing activities | 0.50 | (1.32) | (2.16) | (1.26) | 0.06 | (0.60) | (3.08) |
| Net cash from financing activities | (0.16) | (0.12) | (0.19) | (2.42) | (6.06) | 4.52 | (9.90) |
| Net change in cash | 0.23 | (1.64) | 1.31 | (0.75) | (5.32) | 5.63 | (2.67) |
| Closing cash | 1.57 | 4.91 | 1.87 | 0.89 | 4.63 | 6.61 | 0.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -18.1% | +26.8% | -50.5% | +52.1% | -14.9% | +4.3% | - |
| EBITDA growth | -11.6% | +23.1% | -59.6% | +28.2% | -6.0% | +0.3% | - |
| PBT growth | -14.9% | +57.4% | -70.3% | +78.6% | -5.0% | +17.5% | +21.2% |
| Net income growth | +20.1% | +97.0% | -75.4% | +65.3% | 0.0% | +15.4% | - |
| Revenue CAGR (3Y) | -19.9% | -1.5% | -13.8% | +10.5% | -9.8% | -0.3% | +9.7% |
| EBITDA CAGR (3Y) | -24.0% | -13.9% | -21.3% | +6.5% | -2.8% | -5.6% | +0.7% |
| Profitability & leverage | |||||||
| Net income margin | +8.1% | +5.6% | +3.5% | +6.7% | +6.4% | +5.6% | +5.0% |
| Return on capital employed | +7.8% | +9.9% | +6.9% | +23.3% | +13.3% | +15.9% | +15.7% |
| Return on net worth | +7.8% | +7.1% | +3.7% | +15.9% | +11.3% | +13.3% | +13.1% |
| Debt / equity | 0.03 | 0.03 | 0.04 | 0.08 | 0.26 | 0.32 | 0.48 |
| Long-term debt / equity | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.07 | 0.15 |
| Interest cover | 11.56 | 10.12 | 17.36 | 7.50 | 11.01 | 15.98 | 26.54 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.85 | 1.13 | 0.97 | 2.11 | 1.47 | 1.83 | 1.97 |
| Inventory turnover | 4.59 | 7.03 | 5.53 | 11.91 | 6.13 | 6.82 | 8.20 |
| Debtors turnover | 3.34 | 5.31 | 3.30 | 5.03 | 4.03 | 6.58 | 6.29 |
| EPS (₹) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 | 4.17 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 30.66 | 28.37 | 26.42 | 25.46 | 21.73 | 19.45 | 34.05 |
Peer Comparison of Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited is compared with the companies closest to it by revenue in the Chemicals industry (Specialty Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vimson Coatings Private Limited | ₹39.93 Cr (FY 2024) | •••• | •••• | 78.0% | •••• | Nashik, Maharashtra, India |
| Amogh Chemicals Private Limited | ₹39.66 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Thane, Maharashtra, India |
| Austro Carbon Private Limited | ₹39.25 Cr (FY 2025) | •••• | •••• | 299.0% | •••• | Tuticorin, Tamil Nadu, India |
| Kavin Carbons Private Limited | ₹39.19 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Sattur, Tamil Nadu, India |
| Civentichem (India) Private Limited | ₹39.15 Cr (FY 2024) | •••• | •••• | -52.0% | •••• | Hyderabad, Telangana, India |
| Poorvanchal Acid Private Limited | ₹39.12 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Indore, Madhya Pradesh, India |
| Smaltochem India Private Limited | ₹39.01 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Allegro Speciality Chemicals Private Limited | ₹38.95 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Hyderabad, Telangana, India |
| Blue Star Extrusion Private Limited | ₹38.76 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Sangli, Maharashtra, India |
| Imerys Carbonates India Private Limited | ₹38.64 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Mehsana, Gujarat, India |
| Arvee Laboratories (India) Limited this company | ₹31.51 Cr (FY 2026) | •••• | •••• | -18.1% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Arvee Laboratories (India) by revenue in the Chemicals industry (Specialty Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited is audited by Nirav Patel & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Nirav Patel & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Arvee Laboratories (India) Limited
Arvee Laboratories (India) has 6 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalin Sudhakarbhai Patel | Director | 01 Apr 2014 | 12 Years 6 Months | Current |
| Neetu Jalan | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Sachin Kanwarlal Kansal | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
| Shalini Hitesh Jalan | Director | 26 May 2022 | 4 Years 4 Months | Current |
| Saurin Ajitbhai Gandhi | Director | 12 Aug 2025 | 1 Years 2 Months | Current |
| Praveen Kumar Rameshchandra Mishra | Director | 24 Jun 2024 | 2 Years 3 Months | Current |
Shareholding Pattern of Arvee Laboratories (India) Limited
Shareholding for the quarter ended Sep 2026: promoters hold 73.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 26.50%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 73.50% | 73.50% | 73.50% | 73.50% |
| Public | 26.50% | 26.50% | 26.50% | 26.50% |
Charges & Borrowings of Arvee Laboratories (India) Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2017 | Standard Chartered Bank | ₹10 Cr | Open |
| 22 Apr 2017 | Standard Chartered Bank | ₹50 Lakh | Open |
| 22 Apr 2017 | Standard Chartered Bank | ₹10 Cr | Open |
| 07 Oct 2013 | Others | ₹15 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited has 1 deal on record (1 ipo); the latest was in February 2018.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2018 | IPO | ₹8.91 Cr | Investors: Public Investors |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited has 5 court cases on record: 1 filed by Arvee Laboratories (India), 4 filed against it. All cases are disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Government of Gujarat | Disposed |
| High Court of Gujarat | Special civil application | Filed by the company against Union of India | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited has 3 MSME Form 1 returns on record for the period ending Mar 2023, listing 83 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Radix Innovations Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Sarvadhar Trading Private Limited | •••• | •••• | •••• |
| Corpack Solutions Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Arvee Laboratories (India) Limited
Arvee Laboratories (India) operates one associated brand: Arvee Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Chemical products including polymer and drug intermediates are manufactured. | arveelabs.com |
Employees and EPFO Compliance at Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited has a workforce of 66 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Arvee Laboratories (India) Limited
Arvee Laboratories (India) has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24231GJ2012PLC068778, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231GJ2012PLC068778 | Current |
| U24231GJ2012PTC068778 | Previous |
| U24231GJ2012PLC068778 | Previous |
Recent Activity on Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited has 27 board changes on record since 2012: 17 appointments and 10 cessations. The latest: Saurin Ajitbhai Gandhi was appointed as Director on 12 Aug 2025.
26 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Arvee Laboratories (India) Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arvee Laboratories (India) Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arvee Laboratories (India) Limited
Arvee Laboratories (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAKCA2207N1ZQ | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arvee Laboratories (India) Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Arvee Laboratories (India) Limited
Frequently Asked Questions about Arvee Laboratories (India) Limited
Arvee Laboratories (India) is an active public limited company based in Ahmedabad, Gujarat, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 27 January 2012 (14+ years old) and is registered under CIN L24231GJ2012PLC068778. Listed on NSE: ARVEE.
Arvee Laboratories (India) reported revenue of ₹31.51 Cr for FY 2025-26 (down 18.1% YoY) based on standalone financials.
Arvee Laboratories (India) has 6 current directors:
- Shalin Sudhakarbhai Patel - Director
- Neetu Jalan - Director
- Sachin Kanwarlal Kansal - Director
- Shalini Hitesh Jalan - Director
- Saurin Ajitbhai Gandhi - Director
- Praveen Kumar Rameshchandra Mishra - Director
The GSTIN of Arvee Laboratories (India) is 24AAKCA2207N1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Arvee Laboratories (India) is L24231GJ2012PLC068778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Arvee Laboratories (India) is listed on NSE with symbol ARVEE.
Arvee Laboratories (India) has 5 court cases on record: 1 filed by the company and 4 filed against it. Most are in the district courts.
Arvee Laboratories (India) was incorporated on 27 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Arvee Laboratories (India) has 1 deal on record (1 ipo); the latest was in February 2018.
The peers of Arvee Laboratories (India) by revenue are Vimson Coatings Private Limited, Amogh Chemicals Private Limited, Austro Carbon Private Limited, Kavin Carbons Private Limited, Civentichem (India) Private Limited and 5 more, all in the Chemicals industry (Specialty Chemicals).
Saurin Ajitbhai Gandhi was appointed as Director on 12 Aug 2025. Shalin Bharatbhai Chokshi ceased to be Whole-Time Director on 30 Jun 2025. Praveen Kumar Rameshchandra Mishra was appointed as Director on 24 Jun 2024. Arvee Laboratories (India) has 27 board changes on record in total.
Arvee Laboratories (India) has 3 MSME Form 1 returns on record for the period ending Mar 2023, listing 83 overdue payments to 22 micro and small suppliers. The latest return was filed on 04 Dec 2023.